Closing the Loop in Target Discovery: Applying Foundation Models and AI to Targeted Identification in ADPKD
Wednesday, June 3, 2026 2:10 PM to 2:40 PM · 30 min. (US/Eastern)
AI in Drug Discovery Stage
Day 1
AIDrug Discovery
Information
- This talk presents a systematic framework for applying artificial intelligence to targeted identification in autosomal dominant polycystic kidney disease (ADPKD), using fine‑tuned biological foundation models to support disease‑specific target prioritization.
- The presentation focuses on methodological considerations, model selection and benchmarking strategies, and best practices for evaluating AI‑driven target discovery, using enrichment‑ and hit‑rate–based metrics.
